Singapore markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.60+0.34 (+3.62%)
As of 09:49AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-201,592
-201,592
-197,723
-143,883
-129,068
Depreciation & amortisation
575
575
620
521
323
Stock-based compensation
45,025
45,025
24,133
16,812
5,840
Change in working capital
-13,644
-13,644
5,438
-27,315
51,717
Accounts receivable
-1,637
-1,637
0
-
-
Inventory
-9,442
-9,442
0
-
-
Accounts payable
6,410
6,410
8,679
-9,791
24,009
Other working capital
-139,214
-139,214
-147,571
-148,785
-70,728
Other non-cash items
32,056
32,056
21,002
5,408
1,595
Net cash provided by operating activities
-137,580
-137,580
-146,530
-148,457
-69,688
Cash flows from investing activities
Investments in property, plant and equipment
-1,634
-1,634
-1,041
-328
-1,040
Net cash used for investing activities
-1,634
-1,634
-1,041
-328
-1,040
Cash flows from financing activities
Debt repayment
-
-
0
-54,125
0
Common stock issued
155,463
155,463
24,596
0
88,830
Other financing activities
172,675
172,675
95,446
-
-
Net cash used provided by (used for) financing activities
367,580
367,580
120,042
44,708
114,459
Net change in cash
228,366
228,366
-27,529
-104,077
43,731
Cash at beginning of period
155,890
155,890
183,419
287,496
243,765
Cash at end of period
384,256
384,256
155,890
183,419
287,496
Free cash flow
Operating cash flow
-137,580
-137,580
-146,530
-148,457
-69,688
Capital expenditure
-1,634
-1,634
-1,041
-328
-1,040
Free cash flow
-139,214
-139,214
-147,571
-148,785
-70,728